NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CorVista Health

CorVista Health

Private
Bethesda, MarylandHealthcare & Life Scienceshttps://corvista.com/

Last Round

Series C

Mar 4, 2021

Total Funding Raised

$106.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

CorVista Health is a medical technology company that develops a non-invasive, AI-driven diagnostic platform for the rapid evaluation of cardiovascular conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting

AI Layer

Application

Keywords

point-of-care diagnosticscardiovascular AInon-invasive diagnosticsmedical AIcoronary artery diseaseCADpulmonary hypertensionischemia with non-obstructive coronary arteriesINOCAAI diagnostic softwaremedical device as a serviceMDaaScurrent procedural terminologyCPT codeclinical decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CorVista Health Comparables

Compare CorVista Health with similar companies based on industry and business-model similarity.

CorVista Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Elucid
80%
Anumana
79%
Cleerly
78%

CorVista Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 4, 2021
Series BSep 27, 2017
Series AJun 21, 2016

Key People

Founding team and executive leadership

Adrian Lam

Chief Executive Officer

Executive Team

Theresa A. Matacia

Consulting CFO

Executive Team

CorVista Health Investors

Notable investors and investment history

CorVista Health investors
InvestorRounds
Ambix Life Science Fund I, L.P.Series C
MedVenture PartnersSeries C
CincyTechSeries A
Ontario Centre of InnovationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 29, 2026

    Partnered to advance the diagnosis of next-generation pulmonary hypertension.

  • Oct 1, 2025

    Dino Trevisani has joined the Board of Directors.

CorVista Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CorVista Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CorVista Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBethesda, Maryland
Employee Range26
Year Founded2012
Last FundingMar 4, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.